Occupancy of specific receptors on neutrophils by adenosine or its analogues diminishes the stimulated release of toxic oxygen metabolites from neutrophils, while paradoxically promoting chemotaxis. We now report evidence that two distinct adenosine receptors are found on neutrophils (presumably the Al and A2 receptors of other cell types). These adenosine receptors modulate chemotaxis and 02 generation, respectively. N6-Cyclopentyladenosine (CPA), a selective A, agonist, promoted neutrophil chemotaxis to the chemoattractant FMLP as well as or better than 5'N-ethylcarboxamidoadenosine (NECA). In contrast, CPA did not inhibit O2 generation stimulated by FMLP. Pertussis toxin completely abolished promotion of chemotaxis by CPA but enhanced inhibition by NECA of 02 generation. Disruption of microtubules by colchicine or vinblastine also abrogated the enhancement by NECA of chemotaxis whereas these agents did not markedly interfere with inhibition by NECA of°2 generation. FMLP receptors, once they have bound ligand, shift to a high affinity state and become associated with the cytoskeleton. NECA significantly increased association of I3HIFMLP with cytoskeletal preparations as it inhibited 2.-Disruption of microtubules did not prevent NECA from increasing association of PHIFMLP with cytoskeletal preparations. Additionally, CPA (Al agonist) did not increase binding of IHIFMLP to the cytoskeleton as well as NECA (A2 agonist). These studies indicate that occupancy of one class of adenosine receptors (Al) promotes chemotaxis by a mechanism requiring intact microtubules and G proteins whereas engagement of a second class of receptors (A2) inhibits 0-generation. Signalling via A2 receptors is independent of microtubules, insensitive to pertussis toxin and is associated with binding of [HjFMLP to cytoskeletal preparations.
Introduction
Inflammation is the primary response to tissue injury or microbial invasion and is characterized by the local accumula-tion of neutrophils. While neutrophils are essential for limiting the spread of infection, stimulated neutrophils are capable of damaging injured tissues while en route to sites of infection or inflammation. We have recently discovered that release of adenosine is one mechanism by which normal cells may protect themselves from activated neutrophils (1) . Extracellular adenosine and its analogues diminish generation of toxic oxygen products (e.g., O2 or H202) by activated neutrophils, yet promote neutrophil chemotaxis (2-4). No other known physiologic agent affects neutrophil function in such a paradoxical fashion.
We and others have previously reported that adenosine and its analogues inhibit O2 generation by occupying specific adenosine A2 receptors on the neutrophil (2, 3, 5, 6 ). More recently we have reported that adenosine occupies a similar receptor to promote chemotaxis (2, 4) . Thus, the order of potency of various adenosine analogues for inhibition of O2 generation is identical to the order of potency of these analogues for promotion of chemotaxis (5'N-ethylcarboxamidoadenosine [NECA] )' > adenosine > N6-phenylisopropyladenosine [2, 4] ). However, we have observed that NECA, the most potent inhibitor of O°generation and promoter of chemotaxis described to date, promotes chemotaxis at concentrations much lower than those required for inhibition of O2 generation (ECs0 9 pM vs. ICso 17 nM, respectively [2, 4] ). The discrepancy between the potency of NECA for inhibition of O2 generation and promotion of chemotaxis suggests that either occupancy of fewer adenosine receptors is required to promote chemotaxis than inhibit O2 generation or that occupancy of separate adenosine receptors inhibits O2 generation or promotes chemotaxis. We now report evidence that neutrophils possess two pharmacologically distinct adenosine receptors (consistent with Al and A2 by the classification of van Calker et al. [7] ) which, when occupied, modulate chemotaxis and O2 generation, respectively, in response to the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine (FMLP). Adenosine, acting at Al receptors, promotes chemotaxis by a mechanism that requires intact G proteins and microtubules. In 
Results
We studied the effect of four adenosine receptor agonists on stimulated neutrophil functions. These adenosine analogues differ greatly with respect to their potency as agonists at adenosine receptor subtypes (as determined by inhibition of ligand binding in rat brain preparations [ 13] ). The agent that we have previously shown to be the most potent promoter of chemotaxis and inhibitor of O°generation, NECA, is equally potent at A1 and A2 receptors. We have now studied the 600-to 700-fold Al specific agonist N6-cyclopentyladenosine (CPA) and two relatively A2 specific adenosine analogues: 2-phenylaminoadenosine (CV-1808, five-to sevenfold A2-specific) and 2-para-2-carboxyethylphenylamino-5'N-ethylcarboxamidoadenosine (CGS-21680, 140-fold A2 specific) (13 Adenosine Al and A2 receptors also differ from each other by the mechanisms through which, when occupied, they influence intracellular events. Stimulus-response coupling at adenosine Al receptors proceeds via GTP binding (G) proteins which are inactivated after incubation with pertussis toxin ( 14-21). To further confirm that adenosine and its analogues promote chemotaxis by engaging Al receptors we studied the effect of CPA on chemotaxis in the presence or absence of pertussis toxin. We found that pertussis toxin completely abrogated the ability of CPA to promote chemotaxis (Fig. 2 a) . In contrast, pertussis toxin potentiated, minimally, inhibition of O°generation by NECA (Fig. 2 b) .
We next explored the possibility that cytoskeletal elements are required for adenosine to either promote chemotaxis or inhibit O-generation. We therefore determined whether disruption of neutrophil microtubules by colchicine or vinblastine, agents that disrupt neutrophil microtubules without markedly affecting neutrophil chemotaxis (22, 23) , interfered with the effect ofadenosine receptor agonists on chemotaxis or 02 generation. Both vinblastine and colchicine completely abrogated the effect of NECA on chemotaxis (Fig. 3 a) . In contrast, neither vinblastine nor colchicine markedly interfered with the ability of NECA to inhibit 02 generation (Fig. 3  b) . Identical results were obtained using the more selective A2 agonist CGS-21680 (Table II) . These Agonist Concentration (nM The data from which these figures are derived are shown in Fig. 1 One mechanism by which adenosine could inhibit 02 generation is to "desensitize" the neutrophil to stimulation by chemoattractant. Recent studies by Jesaitis and co-workers have suggested that after activation of the neutrophil, chemoattractant-receptor complexes associate with a cytoskeletal fraction (12). Association of chemoattractant receptors with the cytoskeleton is linked to inability of the neutrophil to generate 02 in response to chemoattractant (37) . We therefore studied the effect of adenosine receptor agonists on association of FMLP receptors with the "cytoskeleton" to determine whether adenosine receptor occupancy inhibits 02 generation stimulated by FMLP by desensitizing FMLP receptors. Labeled FMLP associated with the cytoskeleton in a time dependent fashion, as previously reported (12). The adenosine receptor agonist NECA significantly increased association of [3H]FMLP with the cytoskeleton at all time points after 30 s (Fig. 4) . We next sought to determine whether increased association of FMLP with the cytoskeleton is associated with inhibition of O2 generation and/or promotion of chemotaxis. We therefore (Table  III) . Since we had shown that disruption of microtubules by vinblastine and colchicine abrogated the effect of adenosine receptor agonists on chemotaxis without affecting inhibition by adenosine receptor agonists of O2 we studied the effect of NECA on [3H]FMLP binding to the cytoskeleton in the presence of colchicine and vinblastine. Vinblastine and colchicine interfered with neither the binding of [3HJFMLP to the cytoskeleton nor the increment in [3HJFMLP binding to cytoskeletal fractions due to NECA (Table IV) with the cytoskeleton in a manner that parallels inhibition of O2 generation but not promotion of chemotaxis.
Discussion
These data demonstrate the presence oftwo distinct adenosine receptors on neutrophils which, when occupied, inhibit stimulated O2 generation or promote chemotaxis. The receptor by which adenosine and its analogues modulate chemotaxis re- The reaction was terminated by addition of a fourfold excess of iced buffer followed by washing at 40C, lysis with Triton X-100 (0.5%) and centrifugation of insoluble material through an 8% sucrose gradient in a microcentrifuge (900 g for 5 min at 40C). The radioactivity associated with the Triton X-100 insoluble material was then quantitated. The specific binding was calculated after subtraction of nonspecific binding from total binding. The results shown represent the mean±SEM of three to six separate experiments performed in triplicate. nism that requires intact microtubules. In contrast, the receptor by which adenosine and its analogues inhibit O2 generation is of relatively low affinity (IC50 for°2 generation in the nanomolar range) and does not depend upon functional G proteins or intact microtubules to inhibit stimulated Q2 generation, an interaction consistent with occupancy of an A2 receptor. Alternatively, the adenosine receptors present on neutrophils may represent one or two new classes of adenosine receptor since ligands that are A2 specific (CGS-21680 and CV-1808) in other cells or species do not differentiate in their potency between inhibition of O2 generation and promotion of chemotaxis.
The mechanism by which adenosine receptor occupancy inhibits O2 generation has not been well understood. Previous studies have shown that adenosine receptor occupancy does not inhibit°2 generation by altering stimulated Ca2l metabolism, Na'-H' pumps or increasing intracellular levels ofcAMP (31) (32) (33) . Our results suggest one mechanism by which adenosine receptor occupancy inhibits O°generation by activated (53) . These studies suggest that adenosine plays a unique role in modulation of inflammation. The concentration of adenosine present in blood (-0.3 ,M, Cronstein, B. N., and J. E. Slater, unpublished data, [54] ) is sufficient to markedly inhibit generation of toxic oxygen compounds thereby protecting vascular endothelium from damage by activated neutrophils (1) . At the low concentrations of adenosine that may be present in the relatively acellular extravascular tissues on the periphery of inflammatory sites adenosine occupies high affinity receptors on neutrophils to promote directed migration toward infected or inflammatory loci. At the higher concentrations of adenosine that are present at sites ofinjured (but not necrotic) tissues (55) occupancy of low affinity adenosine receptors inhibits the generation of toxic oxygen metabolites by activated neutrophils, thereby protecting injured tissues from further damage by activated neutrophils en route to sites of inflammation.
Dead cells release their cytoplasmic enzymes including adenosine deaminase (unpublished observations, Marchetta, P., and B. N. Cronstein). This ubiquitous cytoplasmic enzyme, when released from dead or dying cells, can degrade adenosine to inosine, thereby permitting neutrophils to release greater quantities of bactericidal oxygen metabolites such as O°and H202 (40, 56) .
